NewcelX Market Risk Adjusted Performance
| NCEL Stock | | | 2.74 -0.05 -1.79% |
NewcelX market risk adjusted performance lookup summarizes this and related technical indicators for NewcelX. Coverage depends on data availability and normalization;
Equity Screeners provides additional screening context. NewcelX has a market cap of 12.49 M. Use
Correlation Analysis to explore allocation context. This includes a position in NewcelX in the portfolio view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in discontinued.
To learn how to invest in NewcelX Stock, please use our
How to Invest in NewcelX guide.
NewcelX has current Market Risk Adjusted Performance of 2.82.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | 2.82 | |
| ER[a] | = | Expected return on investing in NewcelX |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
NewcelX Market Risk Adjusted Performance Peers Comparison
NewcelX Market Risk Adjusted Performance Relative To Other Indicators
NewcelX sits atop the peer group for market risk adjusted performance within its peer group. It is currently under evaluation for maximum drawdown within its peer group where Maximum Drawdown runs almost
13.97 per Market Risk Adjusted Performance. NewcelX's Maximum Drawdown registers at
13.97 relative to Market Risk Adjusted Performance
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.